Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation

BACKGROUND: Pediatric patients undergoing hematopoietic stem cell transplantation (HSCT) are at high risk of acquiring fungal infections. Antifungal prophylaxis shortly after transplantation is therefore indicated, but data for pediatric patients under 12 years of age are scarce. To address this iss...

Descripción completa

Detalles Bibliográficos
Autores principales: Döring, Michaela, Müller, Carsten, Johann, Pascal-David, Erbacher, Annika, Kimmig, Astrid, Schwarze, Carl-Philipp, Lang, Peter, Handgretinger, Rupert, Müller, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514296/
https://www.ncbi.nlm.nih.gov/pubmed/23082876
http://dx.doi.org/10.1186/1471-2334-12-263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514296/
https://www.ncbi.nlm.nih.gov/pubmed/23082876
http://dx.doi.org/10.1186/1471-2334-12-263

Ejemplares similares